-
Retrieved 22
October 2020. "
Cellcept-
mycophenolate mofetil tablet, film
coated Cellcept-
mycophenolate mofetil capsule Cellcept-
mycophenolate mofetil hydrochloride...
-
derivative which was
eventually approved as an
immunosuppressive drug
called CellCept. He
contributed more than 400
technical papers and
edited 12 books. Allison...
- 09.006. ISSN 1568-9972. "FDA Alert:
Mycophenolate Mofetil (marketed as
CellCept) and
Mycophenolic Acid (marketed as Myfortic)". U.S. Food and Drug Administration...
- HIV
protease inhibitor Invirase 1999 –
Released immunosuppressive agent Cellcept 2000 –
Released antiemetic drug Kytril,
developed to
combat the side effects...
-
stable angina pectoris.
Cathflo Activase (alteplase), for
heart attacks.
Cellcept (mycophenolate mofetil), for
transplant rejection.
Cotellic (cobimetinib)...
- Lucentis, Xolair, Activase,
Cathflo Activase, Xeloda, Boniva, TNKase,
CellCept, Pegasys, Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn,...
- inebilizumab, satralizumab, rituximab, methylprednisolone, azathioprine,
cellCept, mitoxantrone, methotrexate,
intravenous immunoglobulin, cyclophosphamide...
-
transplant drugs azathioprine (Imuran/Azoran) and
mycophenolate mofetil (
Cellcept). In the U.S.,
these drugs are used "off-label",
meaning that they do not...
-
response measured in
magnetoencephalography Mycophenolate mofetil (tradename
CellCept), an
immunosuppressant drug used to
prevent rejection in
organ transplantation...
- [citation needed]
Second line
therapies include:
mycophenolate mofetil (
cellcept)
which inactivates inosine monophosphate, most
studied in
clinical trials...
